Condor Capital Management Amgen Inc Transaction History

Condor Capital Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $18,093 - $22,989	-79 Reduced 8.12%	894 $234,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $17,956 - $20,252	80 Added 8.96%	973 $219,000
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $11,535 - $12,837	-50 Reduced 5.3%	893 $217,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $187,543 - $214,626	943 New	943 $212,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $188,966 - $209,644	-809 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $179,525 - $209,207	809 New	809 $201,000
Q4 2020 Jan 29, 2021	SELL	$216.38 - $257.67 $175,267 - $208,712	-810 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $16,425 - $18,266	-70 Reduced 7.95%	810 $206,000
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $174,072 - $213,611	880 New	880 $208,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

Stay updated on Condor Capital Management with notifications on news.